National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

denosumab (den-oh-SOO-mab)

 A type of monoclonal antibody being studied in the treatment of multiple myeloma (a cancer that forms in bones) and in the prevention and treatment of bone metastases (cancer that has spread to bone from another organ). Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Denosumab binds to the protein RANKL and helps keep bone from breaking down. Also called AMG 162.



Previous Definitions:dendritic cell, dendritic cell vaccine, denial, denileukin diftitox, denomination
Next Definitions:dental implant, dentist, Denys-Drash syndrome, deoxycytidine, deoxyribonucleic acid

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov